|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/50 | |
| A61K 35/17 | |||
| C12N 5/0783 |
| (11) | Number of the document | 2783692 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13188706.9 |
| Date of filing the European patent application | 2008-09-29 | |
| (97) | Date of publication of the European application | 2014-10-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 995763 P | 2007-09-28 | US | |
| 90555 P | 2008-08-20 | US |
| (72) |
ZHANG, Xiaokui, US
VOSKINARIAN-BERSE, Vanessa A., US
KANG, Lin, US
PADLINA, Neerav Dilip, US
|
| (73) |
Celularity, Inc.,
33 Technology Drive, Warren, NJ 07059,
US
|
| (54) | TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS |
| TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS |